Loading patent…
AssigneesHuman Genome Sciences, Inc., Delta Biotechnology Limited
InventorsCraig A. Rosen, William A. Haseltine, David J. Ballance, Andrew J. Turner, Steven M. Ruben
Estimating the term…
The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disorders or conditions using albumin fusion proteins of the invention.
1-21. (canceled)
An albumin fusion protein comprising an insulin polypeptide fused to albumin, wherein the fusion protein has insulin activity, and wherein:
A method of treating, preventing, diagnosing or ameliorating a disease, disorder or condition in a subject in need thereof comprising administering an effective amount of an albumin fusion protein comprising an insulin polypeptide fused to albumin, wherein the fusion protein has insulin activity, and wherein:
Dependencies are inferred from the claim text.